NYSE:DNALife Sciences
Ginkgo Bioworks Q4 Loss Profile Reinforces Bearish Narratives On Cash Burn And Profit Timing
Ginkgo Bioworks Holdings (DNA) has just wrapped up FY 2025 with Q4 revenue of about US$33.4 million and a basic EPS loss of US$1.41, while net income excluding extra items came in at a loss of US$80.8 million. Over recent quarters the company has seen revenue move from US$89.0 million in Q3 2024 to US$48.3 million in Q1 2025, US$49.6 million in Q2, US$38.8 million in Q3 and US$33.4 million in Q4. This has come alongside basic EPS losses ranging between US$1.08 and US$2.00. Together, these...